★ Sign in to follow
RP

Redwood Pharma AB Stock: price and insider trades · Sweden

ISIN SE0009994676SE·

No insider purchase over the last 90 days. The latest, by Hans Gunnar Ageland, was filed 08 Feb 2021.

Redwood Pharma AB: what insiders have been doing

Redwood Pharma AB is a listed company. Its directors and officers file their transactions with Finansinspektionen. The past year has been quiet: not a single insider filing for Redwood Pharma AB. The previous disclosure was published on 8 September 2023.

Looking back to 2017, when coverage begins, insiders filed 4 purchases and 3 sales.

For comparison within the same market, see the insider buying recorded at Dynavox Group AB and Rusta AB (publ). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.

Insider Decl.
11
Thresholds
n/a
Buy Volume
€17,093
4 ops. · all time
Sell Volume
€5,712
3 ops. · all time

Financial data

· cache

Last declaration on 8 September 2023
Declarations11 total
  • ▼
    Martin Olov Vidaeus
    Verkställande direktör (VD)Executives
    0FI-SE
    579,116 shares0Teckningsrätt/UniträttISIN SE0020678605FI:csv-cc7701c69891e7d529d6
  • ▲
    Hans Gunnar Ageland
    StyrelseledamotExecutives
    35,000 SEK0FI-SE
    5,000 shares@ SEK 7.0026.6% of flowBTA (betald tecknad aktie)ISIN SE0015483185FI:csv-f4d0d4f43c6a88d5b1b0
    Canonical exit: 9 May 2021 (T+90)
  • ●
    Gunnar Mattsson
    Styrelseledamot/suppleantExecutives
    12,363 SEK8FI-SE
    1,318 shares@ SEK 9.386.3% of flowAktieISIN SE0008294789FI:csv-ffbb6226b092666f80ff
  • ▲
    Gunnar Mattsson
    Styrelseledamot/suppleantExecutives
    45,850 SEK9FI-SE
    5,000 shares@ SEK 9.1723.7% of flowAktieISIN SE0008294789FI:csv-d2d9570cf06e596563aa
    Canonical exit: 16 Jun 2020 (T+90)
  • ▼
    Ingrid Atteryd Heiman
    Styrelseledamot/suppleantExecutives
    59,907 SEK27FI-SE
    5,700 shares@ SEK 10.51100.0% of flowAktieISIN SE0008294789FI:csv-71767d66e5686da011f2
  • ▲
    Hans Gunnar Ageland
    Styrelseledamot/suppleant ,COOExecutives
    21,750 SEK0FI-SE
    3,000 shares@ SEK 7.2521.3% of flowBTA (betald tecknad aktie)ISIN SE0013102456FI:csv-2c47c893b76deead3e77
    Canonical exit: 22 Dec 2019 (T+90)
  • ▼
    Hans Gunnar Ageland
    COO,Styrelseledamot/suppleantExecutives
    1,760 SEK0FI-SE
    16,000 shares@ SEK 0.111.7% of flowTeckningsrättISIN SE0013102449FI:csv-06f2dcb8695b628d72ce
  • ▲
    Hans Gunnar Ageland
    COOExecutives
    76,808 SEK19FI-SE
    11,379 shares@ SEK 6.7577.0% of flowISIN SE0011088624FI:csv-d667656ae83d1ac9db33
    Canonical exit: 22 Jul 2018 (T+90)
  • ●
    Gunnar Mattsson
    Styrelseledamot/suppleantExecutives
    52,313 SEK10FI-SE
    7,750 shares@ SEK 6.7526.5% of flowISIN SE0008294789FI:csv-2d1efd83ae0da7201dc4
  • ●
    Gunnar Mattsson
    Styrelseledamot/suppleantExecutives
    49,500 SEK10FI-SE
    15,000 shares@ SEK 3.3027.0% of flowISIN SE0009994676FI:csv-700dc570b6a323c6a358
  • ●
    Gunnar Mattsson
    Styrelseledamot/suppleantExecutives
    33,000 SEK9FI-SE
    10,000 shares@ SEK 3.3018.0% of flowISIN SE0009994676FI:csv-6792c049a74bdfc6d296

11 of 11 declarations

About Redwood Pharma AB

Redwood Pharma AB is a pharmaceutical company focused on developing treatments for eye diseases. It is listed on the Stockholm Stock Exchange.

Recent ranked signals on the same market

Purchases our model currently ranks for the recommendations list.

All recommendations

Related companies and executives

No related entities found.